| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8242172 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 8 Pages |
Abstract
Conclusions: Hypofractionated high-dose proton beam therapy seems feasible and effective for Stage I NSCLC. Proton beams may contribute to enhanced efficacy and lower toxicity in the treatment of patients with Stage I NSCLC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Masaharu M.D., Koichi M.D., Kenji M.D., Shinji M.D., Hidetsugu M.D., Nobuyoshi M.D., Takayuki M.D., Masashi M.D., Kiyoshi M.D., Yasuyuki M.D.,